Location History:
- San Diego, CA (US) (1994)
- Vista, CA (US) (1997)
Company Filing History:
2 out of 832,812 Years Active: 1994-1997
Title: Ronald J Billing - Innovator in Monoclonal Antibody Research
Introduction
Ronald J Billing is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of monoclonal antibodies, with a focus on their diagnostic and therapeutic applications in cancer and autoimmune diseases. With a total of 2 patents, his work has had a profound impact on medical research and treatment options.
Latest Patents
Billing's latest patents include groundbreaking innovations. The first patent describes a monoclonal antibody specific for activated lymphocytes and monocytes. This hybrid cell line produces monoclonal antibodies that react with human activated lymphocytes, monocytes, and cancer cells, targeting a growth factor of approximately 15,000 daltons. The diagnostic and therapeutic uses of this antibody and antigen in cancer, autoimmune disease, and transplant rejection are thoroughly discussed.
The second patent focuses on monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells. This monoclonal antibody recognizes a distinct autocrine growth factor, which is a small glycoprotein that differs from interleukin 2 and other known growth factors in function, structure, and tissue distribution. The patent also discloses the therapeutic uses of synthetic analogues and peptide derivatives of the antigen.
Career Highlights
Throughout his career, Ronald J Billing has demonstrated a commitment to advancing medical science through his innovative research. His work has not only contributed to the understanding of immune responses but has also paved the way for new therapeutic strategies in treating various diseases.
Collaborations
One of his notable collaborators is Paul I Terasaki, with whom he has worked closely on various projects related to monoclonal antibodies and their applications in medicine.
Conclusion
Ronald J Billing's contributions to the field of monoclonal antibodies have established him as a key figure in medical research. His innovative patents continue to influence the development of diagnostic and therapeutic solutions for critical health issues.